Model Orchard Shows Latest in Nutrition Management – AG INFORMATION NETWORK OF THE WEST – AGInfo Ag Information Network Of The West

Tim Hammerich

News Reporter

With California Ag Today, I’m Tim Hammerich.

Almond growers now have a way to see how new nutrition programs perform on a commercial scale orchard. YARA International has an incubator farm in Modesto. Here’s permanent crops manager Devin Clarke.

Clarke… “This was something that was launched not two years ago now, as a new part of our approach to really better understand how our recommendations and our understanding of crop nutrition management can be refined with the support of collaborators. And working with industry members and advisors and growers, to be able to further refine those over time.”

Clarke says they are not just looking at performance on the commercial scale orchard that they rent from a local grower. YARA is also looking at the economics of the program to communicate the return on investment to growers.

Clarke… “If we don’t have the economic component in there, it really does not do justice to the practices that we’re implementing. And so we are reporting on our ROI, year in and year out, as far as net returns to the grower. And so what we were able to find within the course of the first full season that we were there, is that after we paid for the premium program, or the premium management practices that we prescribed, we were able to produce an extra $750 an acre back to the grower.”

This is one way that companies like YARA are helping growers to reduce the risk of trying new products.

from WordPress https://ift.tt/3ySuM3k
via IFTTT

Comments

Covid-19 News: F.D.A. Panel to Meet This Week on Moderna and J. & J. Boosters – The New York Times

Image A vaccination site in Spain, where the health regulator approved the use of third Covid-19 vaccination shots for immunocompromised people in September. Credit… Zowy Voeten/Getty Images Severely or moderately immunocompromised people who have been vaccinated should be offered an additional dose of the seven coronavirus vaccines the World Health Organization has authorized, an advisory committee recommended on Monday. People whose immune systems are diminished should get another shot if they initially received vaccines made by Pfizer-BioNTech, Moderna, AstraZeneca, the Serum Institute of India, Johnson & Johnson, Sinopharm and Sinovac, members of the Strategic Advisory Group of Experts on Immunization told reporters on a call on Monday. Dr. Alejandro Cravioto, the committee’s chair, said that people with compromised immune systems “need a third dose as an additional priming process so that they’re fully protected.” The officials also recommended a third vaccine ...

COVID-19 live updates: Pfizer to seek approval for adult boosters, source says – WOKV

NEW YORK — As the COVID-19 pandemic has swept the globe, more than 5 million people have died from the disease worldwide, including over 756,000 Americans, according to real-time data compiled by Johns Hopkins University’s Center for Systems Science and Engineering. Just 68.4% of Americans ages 12 and up are fully vaccinated against COVID-19, according to data from the U.S. Centers for Disease Control and Prevention. Latest headlines: -US surgeon general releases guide to combating COVID-19 vaccine misinformation -Pfizer to request OK for boosters to all adults: Source -US reopens borders to vaccinated travelers Here’s how the news is developing. All times Eastern. Nov 09, 2:42 pm Aaron Rodgers: ‘To anybody who felt misled … I take full responsibility’ Green Bay Packers quarterback Aaron Rodgers says he takes full responsibility for anyone who felt mislead by his comments about his vaccination status. “I do realize I am a role model,” Rodgers said on “The Pat McAfee Show” Tu...

The F.D.A. is aiming to give full approval to Pfizer’s Covid vaccine on Monday. – The New York Times

Coronavirus Updates Aug. 21, 2021 Updated Aug. 21, 2021, 10:11 p.m. ET Aug. 21, 2021, 10:11 p.m. ET Pfizer vaccines were administered at the St. John Chrysostom Catholic Parish in The Bronx on Sunday. Credit… James Estrin/The New York Times The Food and Drug Administration is pushing to approve Pfizer-BioNTech’s two-dose Covid-19 vaccine on Monday, further expediting an earlier timeline for licensing the shot, according to people familiar with the agency’s planning. Regulators were working to finish the process by Friday but were still working through a substantial amount of paperwork and negotiation with the company. The people familiar with the planning, who were not authorized to speak publicly about it, cautioned that the approval might slide beyond Monday if some components of the review need more time. An F.D.A. spokeswoman declined to comment. The agency had recently set an unofficial deadline for approval of around Labor Day. The approval is expected to ...

Dee Lee

Search This Blog